default author photo

Naoko Iwata

National Institute of Infectious Diseases - Department of Pathology

1-23-1 Toyama Shinjuku Yokyo

Japan

SCHOLARLY PAPERS

3

DOWNLOADS

172

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Altered Immune Landscapes and Clonal Responses to COVID-19 Vaccination in People Living with HIV: Insights from Single-Cell Transcriptomics and Repertoire Analysis

Number of pages: 34 Posted: 31 May 2025
Faith Jessica Paran, Mizue Saita, Rieko Oyama, Abdullah Khasawneh, Kaori Saito, Songling Li, Noriyo Nagata, Naoko Iwata, Satomi Takei, Yuki Horiuchi, Yuki Uehara, Yasushi Okazaki, Tadaki Suzuki, Kazuhisa Takahashi, Daron M. Standley, Yoko Tabe and Toshio Naito
Juntendo University, Juntendo University, Juntendo University, Juntendo University, Juntendo University - Department of Clinical Laboratory, The University of Osaka, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Juntendo University, Juntendo University, Juntendo University, Juntendo University, National Institute of Infectious Diseases, Juntendo University - Department of Respiratory Medicine, The University of Osaka, Juntendo University - Department of Clinical Laboratory and Juntendo University - Department of General Medicine
Downloads 96 (725,554)

Abstract:

Loading...

HIV, COVID-19 vaccinations, immunology, infectious diseases, single-cell RNA

2.

Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable Site

Number of pages: 52 Posted: 01 Apr 2021
Taishi Onodera, Shunsuke Kita, Yu Adachi, Saya Moriayma, Akihiko Sato, Takao Nomura, Takeshi Inoue, Takashi Tadokoro, Yuki Anraku, Kohei Yumoto, Cong Tian, Hideo Fukuhara, Michihito Sasaki, Yasuko Orba, Nozomi Shiwa, Naoko Iwata, Noriyo Nagata, Tateki Suzuki, Jiei Sasaki, Tsuyoshi Sekizuka, Keisuke Tonouchi, Shuetsu Fukushi, Hiroyuki Satofuka, Yasuhiro Kazuki, Lin Sun, Mitsuo Oshimura, Tomohiro Kurosaki, Makoto Kuroda, Tadaki Suzuki, Hirofumi Sawa, Takao Hashiguchi, Katsumi Maenaka and Yoshimasa Takahashi
National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Hokkaido University - Laboratory of Biomolecular Science, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Center for Research and Education on Drug Discovery, Osaka University - Laboratory of Lymphocyte Differentiation, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Laboratory of Biomolecular Science, Hokkaido University - Division of Molecular Pathobiology, Hokkaido University - Division of Molecular Pathobiology, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Kyushu University - Department of Virology, Kyushu University - Department of Virology, National Institute of Infectious Diseases - Pathogen Genomic Center, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Department of Virology I, Tottori University - Chromosome Engineering Research Center, Tottori University - Chromosome Engineering Research Center, National Institute of Infectious Diseases - Department of Immunology, Trans Chromosomics Inc., Osaka University - Laboratory of Lymphocyte Differentiation, National Institute of Infectious Diseases - Pathogen Genomic Center, National Institute of Infectious Diseases - Department of Pathology, Hokkaido University - Division of Molecular Pathobiology, Kyushu University - Department of Virology, Hokkaido University - Laboratory of Biomolecular Science and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development
Downloads 49 (1,074,648)

Abstract:

Loading...

3.

Intranasal Vaccination Induced Cross-Protective Secretory IgA Antibodies Against SARS-CoV-2 Variants with Reducing the Potential Risk of Lung Eosinophilic Immunopathology

Number of pages: 48 Posted: 16 Jun 2022
Takuya Hemmi, Akira Ainai, Takao Hashiguchi, Minoru Tobiume, Takayuki Kanno, Naoko Iwata, Shun Iida, Yuko Sato, Sho Miyamoto, Akira Ueno, Kaori Sano, Shinji Saito, Nozomi Shiwa, Noriyo Nagata, Koji Tamura, Ryosuke Suzuki, Hideki Hasegawa and Tadaki Suzuki
National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Kyoto University, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases, National Institute of Infectious Diseases - Department of Pathology, National Institute of Infectious Diseases - Department of Pathology, Tokyo University of Science - Department of Biological Science and Technology, National Institute of Infectious Diseases - Department of Virology II, National Institute of Infectious Diseases and National Institute of Infectious Diseases
Downloads 27 (1,359,097)

Abstract:

Loading...

intranasal vaccination, secretory IgA antibody, COVID-19, SARS-CoV-2, lung eosinophilic immunopathology